Oral Morphine Weaning for Neonatal Abstinence Syndrome at Home Compared with In-Hospital: An Observational Cohort Study

详细信息    查看全文

• 作者：Lauren E. Kelly ; David Knoppert ; Henry Roukema ; Michael J. Rieder…
• 刊名：Pediatric Drugs
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：17
• 期：2
• 页码：151-157
• 全文大小：373 KB
• 参考文献：1. Women ACoHCfU, American Society of Addiction M. ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119(5):1070-.
  2. Services USDoHaH. National Survey on Drug Use and Health: Summary of National Findings. 2010; Available from p://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm" class="a-plus-plus">http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm.
  3. Pinto, SM, Dodd, S, Walkinshaw, SA, Siney, C, Kakkar, P, Mousa, HA (2010) Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 150: pp. 137-141 p://dx.doi.org/10.1016/j.ejogrb.2010.02.026" target="_blank" title="It opens in new window">CrossRef
  4. Seligman NS, Salva N, Hayes EJ, Dysart KC, Pequignot EC, Baxter JK. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol. 2008;199(4):396 e1-.
  5. Bateman, BT, Hernandez-Diaz, S, Rathmell, JP, Seeger, JD, Doherty, M, Fischer, MA (2014) Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology 120: pp. 1216-1224 p://dx.doi.org/10.1097/ALN.0000000000000172" target="_blank" title="It opens in new window">CrossRef
  6. Castro, A, Jones, HE, Johnson, RE, Gray, TR, Shakleya, DM, Huestis, MA (2011) Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clin Chem 57: pp. 449-458 p://dx.doi.org/10.1373/clinchem.2010.154864" target="_blank" title="It opens in new window">CrossRef
  7. Little, BB, VanBeveren, TT (1996) Placental transfer of selected substances of abuse. Semin Perinatol 20: pp. 147-153 p://dx.doi.org/10.1016/S0146-0005(96)80082-6" target="_blank" title="It opens in new window">CrossRef
  8. Jansson, LM, Pietro, JA, Elko, A, Williams, EL, Milio, L, Velez, M (2012) Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes. Drug Alcohol Depend 122: pp. 213-219 p://dx.doi.org/10.1016/j.drugalcdep.2011.10.003" target="_blank" title="It opens in new window">CrossRef
  9. O’Grady, MJ, Hopewell, J, White, MJ (2009) Management of neonatal abstinence syndrome: a national survey and review of practice. Arch Dis Child Fetal Neonatal Edition 94: pp. F249-F252 p://dx.doi.org/10.1136/adc.2008.152769" target="_blank" title="It opens in new window">CrossRef
  10. Sarkar, S, Donn, SM (2006) Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol Off J Calif Perinat Assoc 26: pp. 15-17 p://dx.doi.org/10.1038/sj.jp.7211427" target="_blank" title="It opens in new window">CrossRef
  11. Agthe, AG, Kim, GR, Mathias, KB, Hendrix, CW, Chavez-Valdez, R, Jansson, L (2009) Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics 123: pp. e849-e856 p://dx.doi.org/10.1542/peds.2008-0978" target="_blank" title="It opens in new window">CrossRef
  12. Finnegan, LP, Connaughton, JF, Kron, RE, Emich, JP (1975) Neonatal abstinence syndrome: assessment and management. Addict Dis 2: pp. 141-158
  13. Kelly, JJ, Davis, PG, Henschke, PN (2000) The drug epidemic: effects on newborn infants and health resource consumption at a tertiary perinatal centre. J Paediatr Child Health 36: pp. 262-264 p://dx.doi.org/10.1046/j.1440-1754.2000.00492.x" target="_blank" title="It opens in new window">CrossRef
  14. Patrick, SW, Schumacher, RE, Benneyworth, BD, Krans, EE, McAllister, JM, Davis, MM (2012) Neonatal abstinence syndrome and associated health care expenditures: United states, 2000-009. JAMA 307: pp. 1934-1940 p://dx.doi.org/10.1001/jama.2012.3951" target="_blank" title="It opens in new window">CrossRef
  15. Backes, CH, Backes, CR, Gardner, D, Nankervis, CA, Giannone, PJ, Cordero, L (2012) Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J Perinatol Off J Calif Perinatal Assoc 32: pp. 425-430 p://dx.doi.org/10.1038/jp.2011.114" target="_blank" title="It opens in new window">CrossRef
  16. Liu, A, Bjorkman, T, Stewart, C, Nanan, R (2011) Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea. Int J Pediatr 2011: pp. 935631 p://dx.doi.org/10.1155/2011/935631" target="_blank" title="It opens in new window">CrossRef
  17. Kelly LE, Rieder MJ, Bridgman-Acker K, Lauwers A, Madadi P, Koren G. Are infants expose
• 刊物主题：Pediatrics; Pharmacotherapy; Internal Medicine;
• 出版者：Springer International Publishing
• ISSN：1179-2019

文摘

Objective The objective of this observational study was to evaluate the safety and effectiveness of discharging stabilized neonates to complete their oral morphine weaning at home. Study Design This retrospective cohort study evaluated neonates treated with oral morphine at two hospitals in London, Ontario, Canada. Neonates who completed their morphine wean in hospital were compared with neonates who completed their morphine wean following discharge from hospital (at home). Results There were 80 neonates treated with oral morphine at two hospitals from 2006 to 2010. The majority (65?%, 52/80) of neonates completed their morphine weaning after hospital discharge and were significantly less likely to return to hospital for further withdrawal treatment (1/52 vs 4/28, p?p? Conclusions We present the first North American cohort of neonates weaned with morphine at home for neonatal abstinence syndrome (NAS). We found that more days on oral morphine resulted in fewer returns to hospital for continued withdrawal management. There was no evidence of increased effectiveness, measured by the number of returns to hospital for further NAS management with in-hospital weaning. The estimated cost savings of continued weaning upon discharge was approximately $11,000 per patient (Canadian dollars). While further prospective research is necessary, in some cases morphine weaning at home may present a safe and cost-effective strategy for NAS management.